Back to search
FDAFDA · Food and drugs·Recall number Z-0586-2014

TIBIO FEM/FEM NAIL.

Published January 8, 2014 · Recall initiated: November 5, 2013

Summary

FDA records medical device Class II recall Z-0586-2014, published January 8, 2014 and initiated November 5, 2013. Recalling firm: Zimmer, Inc.; Status: Terminated; Reported quantity: 42, 065 units total; Lot: Item Numbers 32-8553-311-11 32-8553-311-13 32-8553-311-15 32-8553-311-17 All lots with an expiration date prior to July 24, 2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Based on a review of historic packaging validations, it was determined that a subset of product packaged at a Zimmer facility required testing to ensure that previously packaged product from this facility met the established requirements for sterile barrier integrity. This testing determined that a packaging tray configuration which consists of an inner and outer sterile tray, resulted in failure

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Zimmer, Inc.
Distributor
Worldwide Distribution.
Lot
Item Numbers 32-8553-311-11 32-8553-311-13 32-8553-311-15 32-8553-311-17 All lots with an expiration date prior to July 24, 2023
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was TIBIO FEM/FEM NAIL. recalled?

Yes. FDA published recall Z-0586-2014 on January 8, 2014. Reported hazard: Based on a review of historic packaging validations, it was determined that a subset of product packaged at a Zimmer facility required testing to ensure that previously packaged product from this facility met the established requirements for sterile barrier integrity. This testing determined that a packaging tray configuration which consists of an inner and outer sterile tray, resulted in failure

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail